Invesaro

Stocks Health care ABSI

NASDAQ · Health care

Absci Corp (ABSI)

Absci Corp brought in $1.6M of revenue over the twelve months to June 30, 2026, down 62.3% from a year earlier. It posted a net loss of $121.1M. In fiscal 2025 capital spending exceeded operating cash flow by $94M. At June 30, 2026 it held $107.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.

Free, no password. An email when ABSI files with the SEC.

Price
$9.97
-7.69% on the day · November 10, 2026
52-week range $2.24 to $12.55
Market cap
$1.7B
Revenue (last 12 months)
$1.6M
-62.3% year on year
Net margin
-7,756.4%

Key facts about Absci Corp

Net worth
Absci Corp has a market value (market cap) of $1.7B at the latest share price, and shareholders' equity of $246.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $2.8M (-38.2% year on year), with a net loss of $115.2M. Over the 12 months to June 30, 2026: revenue $1.6M, net loss $121.1M.
Cash flow
In fiscal 2025 operations used $92.9M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Absci Corp's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Absci Corp does

Absci Corp is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker ABSI.

Revenue and profit by year

Revenue
FY21: $4.8M $4.8M FY21FY21: $4.8M $4.8M FY21FY22: $5.7M $5.7M FY22FY23: $5.7M $5.7M FY23FY24: $4.5M $4.5M FY24FY25: $2.8M $2.8M FY25
Net income
FY21: -$14.4M -$14.4M FY21FY21: -$101M -$101M FY21FY22: -$104.9M -$104.9M FY22FY23: -$110.6M -$110.6M FY23FY24: -$103.1M -$103.1M FY24FY25: -$115.2M -$115.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$2.8M-$120.3M-$115.2M-$0.84-$94M
2024$4.5M-$108.9M-$103.1M-$0.94-$72.8M
2023$5.7M-$115.5M-$110.6M-$1.20-$65.5M
2022$5.7M-$106.8M-$104.9M-$1.15-$97.5M
2021$4.8M-$75.2M-$101M-$2.08-$98.6M
2021$4.8M-$13.3M-$14.4M-$3.19-$13.2M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where ABSI ranks in Health care

Revenue$2.8M
#598 of 751 in Health care · Bottom 20%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Absci Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 27, 2026
  2. August 11, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 46% to $318K versus the same quarter last year; diluted EPS -$0.21 versus -$0.24.
  3. August 11, 2026
  4. June 24, 2026
  5. June 24, 2026
  6. June 5, 2026
  7. May 7, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue fell 82% to $215K versus the same quarter last year; diluted EPS -$0.19 versus -$0.21.
  8. May 7, 2026
  9. April 22, 2026
  10. April 22, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 30, 2026. Insider transactions on SEC

Insider trades

What the people running Absci Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 5 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
October 29, 2026 McClain SeanChief Executive Officer, Director Shares withheld for tax 79,860 $12.10 $966.3K Form 4
October 12, 2026 Jonasson ZachariahCFO / CBO Shares withheld for tax 387 $10.16 $3.9K Form 4
October 12, 2026 Bedrick ToddSVP, CAO Shares withheld for tax 22,325 $10.16 $226.8K Form 4
October 12, 2026 McClain SeanChief Executive Officer, Director Shares withheld for tax 23,293 $10.16 $236.7K Form 4
August 31, 2026 Jonasson ZachariahCFO / CBO Shares withheld for tax 8,320 $8.71 $72.5K Form 4
June 30, 2026 Szela Mary TDirector Bought 12,900 $11.54 $148.9K Form 4
June 24, 2026 McClain SeanChief Executive Officer, Director Shares withheld for tax 59,896 $10.08 $603.5K Form 4
June 4, 2026 Szela Mary TDirector Received as pay 8,400 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ABSI

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Fmr LLC13G, passive with 1 related filers 14.4% 18,386,849 May 12, 2025
ARK Investment Management LLC13G, passive with 1 related filers 8.6% 10,955,089 May 14, 2025
Sean McClain13G, passive 8.3% 10,760,728 May 14, 2025
BlackRock, Inc.13G, passive 7.8% 13,396,310 October 27, 2026
Jeremy C. Green13D, may seek influence with 1 related filers 7.4% 8,282,016 March 5, 2024

Latest filings below 5%: Redmile Group, LLC 4.9% (April 14, 2026); The Vanguard Group 0% (March 26, 2026); Phoenix Venture Partners II, LP 3.7% (May 15, 2025); Alger Associates, Inc. 3.4% (May 15, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 197 managers reported a position.

HolderSharesValueChange on quarter
Fmr LLC25,410,048$294.5M+2,859,051
ARK Investment Management LLC12,925,271$149.8M-800,898
BlackRock, Inc.12,175,302$141.1M+920,108
State Street Corp8,097,308$93.8M+772,450
Ameriprise Financial Inc6,991,763$81M+3,811,622
Redmile Group, LLC6,739,675$78.1M-1,513,641
Vanguard Capital Management LLC6,122,677$71M+236,037
Advanced Micro Devices Inc5,714,285$66.2M0
Adage Capital Partners GP, L.L.C.5,704,820$66.1Mnew
Two Sigma Investments, LP5,493,486$63.7M+2,594,720
D. E. Shaw & Co., Inc.5,239,754$60.7M+4,589,937
Geode Capital Management, LLC3,583,163$41.5M+240,095
Woodline Partners LP2,700,675$31.3M-599,494
Siren, L.L.C.2,474,764$28.7M+674,764
Bvf Inc2,361,674$27.4Mnew
Gem Investment Advisors, LLC2,170,863$25.2M0
Baker Bros. Advisors LP2,134,803$24.7M0
Goldman Sachs Group Inc1,732,324$20.1M+1,140,612
Nuveen, LLC1,723,979$20M+1,381,290
Voloridge Investment Management, LLC1,602,916$18.6Mnew

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

11 insiders reported holding 10,250,057 shares in total, about $102.2M at the last price.

HolderSharesAs of
McClain SeanChief Executive Officer, Director 8,552,402 October 29, 2026
Jonasson ZachariahCFO / CBO 484,918 October 12, 2026
Busch AndreasChief Innovation Officer 421,446 March 12, 2026
Pangalos Menelas NDirector 242,408 June 4, 2026
Bedrick ToddSVP, CAO 199,128 October 12, 2026
Walker Shelby J.Chief Legal Officer 139,775 March 3, 2026
Van Houten FransDirector 73,420 June 4, 2026
Mcginnis Karen KDirector 48,420 June 4, 2026
Sirosh JosephDirector 33,420 June 4, 2026
Rabinovitsj Daniel ADirector 33,420 June 4, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ABSI

What does Absci Corp do?

Absci Corp is a company in the Health care sector, listed on NASDAQ as ABSI. Its shares trade on NASDAQ under the ticker ABSI.

What is Absci Corp's net worth?

Absci Corp has a market value (market cap) of $1.7B at the latest share price, and shareholders' equity of $246.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Absci Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $121.1M on revenue of $1.6M.

How much revenue does Absci Corp make?

Over the twelve months to June 30, 2026 Absci Corp reported revenue of $1.6M. That is 62.3% less than a year earlier.

When did Absci Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from October 30, 2026.

When is Absci Corp's next earnings report?

Absci Corp's next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare ABSI with

Compare ABSI with any company

Follow ABSI

Get an email when Absci Corp files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when ABSI files with the SEC.

Where the numbers come from

Financial figures are the values Absci Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.